These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 12682495)
1. Effect of a surgical aortocaval fistula on monocrotaline-induced pulmonary hypertension. Nishimura T; Faul JL; Berry GJ; Kao PN; Pearl RG Crit Care Med; 2003 Apr; 31(4):1213-8. PubMed ID: 12682495 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Okada K; Tanaka Y; Bernstein M; Zhang W; Patterson GA; Botney MD Am J Pathol; 1997 Oct; 151(4):1019-25. PubMed ID: 9327735 [TBL] [Abstract][Full Text] [Related]
3. Exendin-4 improves cardiovascular function and survival in flow-induced pulmonary hypertension. Roan JN; Hsu CH; Fang SY; Tsai HW; Luo CY; Huang CC; Lam CF J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1661-1669.e4. PubMed ID: 29249493 [TBL] [Abstract][Full Text] [Related]
4. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. Nishimura T; Faul JL; Berry GJ; Vaszar LT; Qiu D; Pearl RG; Kao PN Am J Respir Crit Care Med; 2002 Nov; 166(10):1403-8. PubMed ID: 12406854 [TBL] [Abstract][Full Text] [Related]
5. The role of increased pulmonary blood flow in pulmonary arterial hypertension. van Albada ME; Schoemaker RG; Kemna MS; Cromme-Dijkhuis AH; van Veghel R; Berger RM Eur Respir J; 2005 Sep; 26(3):487-93. PubMed ID: 16135733 [TBL] [Abstract][Full Text] [Related]
6. Ventricular and pulmonary vascular remodeling induced by pulmonary overflow in a chronic model of pretricuspid shunt. Linardi D; Rungatscher A; Morjan M; Marino P; Luciani GB; Mazzucco A; Faggian G J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2609-17. PubMed ID: 24908349 [TBL] [Abstract][Full Text] [Related]
7. Oral sildenafil prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats. Liu H; Liu ZY; Guan Q Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):608-13. PubMed ID: 17670742 [TBL] [Abstract][Full Text] [Related]
8. Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats. Faul JL; Nishimura T; Berry GJ; Benson GV; Pearl RG; Kao PN Am J Respir Crit Care Med; 2000 Dec; 162(6):2252-8. PubMed ID: 11112148 [TBL] [Abstract][Full Text] [Related]
9. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation. Sahara M; Sata M; Morita T; Nakamura K; Hirata Y; Nagai R Circulation; 2007 Jan; 115(4):509-17. PubMed ID: 17242277 [TBL] [Abstract][Full Text] [Related]
10. [Effect of captopril on pulmonary vascular remodeling induced by left-to-right shunt in rats]. Li M; Zhou TF; Liu HM; Hua YM; Wang XM Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):242-5. PubMed ID: 16608085 [TBL] [Abstract][Full Text] [Related]
12. Role of chymase-dependent angiotensin II formation in monocrotaline-induced pulmonary hypertensive rats. Kishi K; Jin D; Takai S; Muramatsu M; Katayama H; Tamai H; Miyazaki M Pediatr Res; 2006 Jul; 60(1):77-82. PubMed ID: 16690960 [TBL] [Abstract][Full Text] [Related]
13. Additive effect of tadalafil and simvastatin on monocrotaline-induced pulmonary hypertension rats. Zhang WH; Liu CP; Zhang YJ; Ji YQ; Lu WX; Zeng Q Scand Cardiovasc J; 2012 Dec; 46(6):374-80. PubMed ID: 22971207 [TBL] [Abstract][Full Text] [Related]
14. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats. Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725 [TBL] [Abstract][Full Text] [Related]
15. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling. Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin. Li XL; Guan RJ; Li JJ J Cardiovasc Pharmacol; 2012 Aug; 60(2):219-26. PubMed ID: 22592772 [TBL] [Abstract][Full Text] [Related]
17. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats. Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924 [TBL] [Abstract][Full Text] [Related]
18. 40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats. Nishimura T; Faul JL; Berry GJ; Veve I; Pearl RG; Kao PN Am J Respir Crit Care Med; 2001 Feb; 163(2):498-502. PubMed ID: 11179130 [TBL] [Abstract][Full Text] [Related]
19. Endothelin converting enzyme inhibitor protects development of right ventricular overload and medial thickening of pulmonary arteries in rats with monocrotaline-induced pulmonary hypertension. Takahashi T; Kanda T; Inoue M; Sumino H; Kobayashi I; Iwamoto A; Nagai R Life Sci; 1998; 63(10):PL137-43. PubMed ID: 9734710 [TBL] [Abstract][Full Text] [Related]
20. Regression of cardiac hypertrophy after closing an aortocaval fistula in rats. Gerdes AM; Clark LC; Capasso JM Am J Physiol; 1995 Jun; 268(6 Pt 2):H2345-51. PubMed ID: 7611486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]